Post Reply
61-80 of 5056
I was lucky, entered late last year...base on friend' s recommendations....
what did your chart guide you late last year? Your chart didn' t tell you it will surge?
Barcalo ( Date: 27-May-2026 23:23) Posted:
Nope. You are very wrong. We had to somehow depend on some chart data for analysis. You obviously wack alot on IX Biopharma? 😂
Winall88 ( Date: 27-May-2026 23:09) Posted:
| Few months ago any chart to guide the blind that it' s going uphill? You obviously not one of those who can make his own decision.. |
|
|
|
Nope. You are very wrong. We had to somehow depend on some chart data for analysis. You obviously wack alot on IX Biopharma? 😂
Winall88 ( Date: 27-May-2026 23:09) Posted:
Few months ago any chart to guide the blind that it' s going uphill? You obviously not one of those who can make his own decision...
Barcalo ( Date: 27-May-2026 23:04) Posted:
| Because it's really going downtrend.... Tomorrow gonna be so too..... |
|
|
|
Few months ago any chart to guide the blind that it' s going uphill? You obviously not one of those who can make his own decision...
Barcalo ( Date: 27-May-2026 23:04) Posted:
Because it's really going downtrend.... Tomorrow gonna be so too.....
Winall88 ( Date: 27-May-2026 22:58) Posted:
| Months ago when its surging, there is no need for chart to guide.. suddenly chart appears... hahah |
|
|
|
Because it's really going downtrend.... Tomorrow gonna be so too.....
Winall88 ( Date: 27-May-2026 22:58) Posted:
| Months ago when its surging, there is no need for chart to guide.. suddenly chart appears... hahah |
|
Months ago when its surging, there is no need for chart to guide.. suddenly chart appears... hahah
Has anything changed drastically over the last few weeks? Git to ask yourself this.
Anyway, to each his own.
Barcalo ( Date: 27-May-2026 22:23) Posted:
| This IX Biopharma was a gem few weeks ago. But they pump n dump till become worthless now.
|
|
It?s always like that one ma.. retailers jump in. Funds will dump to them and hold for a long time.. then when they sell off. Funds will buy back. On repeat mode
Barcalo ( Date: 27-May-2026 22:23) Posted:
| This IX Biopharma was a gem few weeks ago. But they pump n dump till become worthless now.
|
|
See the chart and you will know it's no good..... Very bad for the coming days of trading.....
JurongW ( Date: 27-May-2026 20:32) Posted:
Updated version
 |
|
This IX Biopharma was a gem few weeks ago. But they pump n dump till become worthless now.
I think you are the only Tom Dick Harry
How much shares they sold? At most 1-2% of their holding leh.. if they sold 50%, perhaps you should be worried
SmallSmall ( Date: 27-May-2026 21:21) Posted:
" Noise" ? CEO and Major shareholders selling leh.
Not Tom Dick or Harry.
If you were them, would you sell if you think the company is undervalued?
Not saying it will not go up since the market is flushed with liquidity and syndicates.
But at the same time should be wary also right?
stlimst ( Date: 27-May-2026 20:57) Posted:
For investors, there is nothing to fear.
Do not be put off by the daily price fluctuations and unwarranted ' noise' .
Know and understand the company, the business and the potential.
Staying vested |
|
|
|
If you are a contra player with no means of picking up the shares, then yes, you have to be wary.
If you are an investor, stay the course, the share price will bounce back in time to come .. $0.46..$0.50...$0.60..then $1.
But, do your due diligence, please.
SmallSmall ( Date: 27-May-2026 21:21) Posted:
" Noise" ? CEO and Major shareholders selling leh.
Not Tom Dick or Harry.
If you were them, would you sell if you think the company is undervalued?
Not saying it will not go up since the market is flushed with liquidity and syndicates.
But at the same time should be wary also right?
stlimst ( Date: 27-May-2026 20:57) Posted:
For investors, there is nothing to fear.
Do not be put off by the daily price fluctuations and unwarranted ' noise' .
Know and understand the company, the business and the potential.
Staying vested |
|
|
|
" Noise" ? CEO and Major shareholders selling leh.
Not Tom Dick or Harry.
If you were them, would you sell if you think the company is undervalued?
Not saying it will not go up since the market is flushed with liquidity and syndicates.
But at the same time should be wary also right?
stlimst ( Date: 27-May-2026 20:57) Posted:
For investors, there is nothing to fear.
Do not be put off by the daily price fluctuations and unwarranted ' noise' .
Know and understand the company, the business and the potential.
Staying vested.
Sgvale ( Date: 27-May-2026 19:58) Posted:
| Wait for more update from its recent positive news flow. Revenue up 30% , hope for potential profitabilit |
|
|
|
For investors, there is nothing to fear.
Do not be put off by the daily price fluctuations and unwarranted ' noise' .
Know and understand the company, the business and the potential.
Staying vested.
Sgvale ( Date: 27-May-2026 19:58) Posted:
Wait for more update from its recent positive news flow. Revenue up 30% , hope for potential profitability
Joelton ( Date: 11-May-2026 10:16) Posted:
IX Biopharma - Restructuring of Consumer Business and Update on Proposed Joint Venture with Orion Speciality Labs
Internal Restructuring
- Ligo Pharma Pte Ltd: iX Biopharma is consolidating its consumer business assets (Australian/HK subsidiaries and the WaferiX DTC platform) into this newly incorporated, 100% owned holding company.
- Asset Split: Ligo will be the vehicle for the US strategy . iX retains the Wafermine drug product, regulatory assets, and US Department of Defence (DoD) contract obligations.
- Financial Impact: The Board confirmed this is an intra-group reorganisation with no material impact on consolidated net tangible assets or earnings per share for the current financial year.
US Strategy & Rationale
-
Immediate Commercialization: The 503A/B compounding framework allows for the immediate commercialization of approximately 40 formulations without waiting for FDA approval.
-
DTC Telehealth: The strategy focuses on building a direct-to-consumer telehealth business. The Board notes that these businesses often trade at valuation premiums and benefit from iX' s patented sublingual technology.
-
Peptide Opportunity: iX identifies peptides as a major opportunity following the removal of 12 peptides from the restricted list in early 2026. The company claims a first-mover advantage due to its sublingual delivery technology.
-
Local Manufacturing: The announcement states that US-based manufacturing is operationally necessary to avoid tariff exposure and supply chain uncertainties inherent in shipping from Australia.
- Future Exit: The standalone structure is intended to preserve flexibility for future corporate actions, including potential listings on the SGX-ST or NASDAQ.
Joint Venture Update
- Orion & GLD: iX is in advanced discussions with GLD Partners, LP and Orion Specialty Labs to incorporate Orion into the Ligo structure.
- Status: GLD would become a co-shareholder of Ligo. Discussions have progressed from a simpler arrangement in November 2025 to a more substantive joint venture structure.
|
|
|
|
Updated version
For those keen to get in, hope for share price to reach S3 or 200 EMA. No guarantee it will get there as short-term is in down trend, while long term is still in uptrend.
Looking at the chart, it does resemble a potential bull flag pattern, provided price breakout from the upper boundary of the channel.
JurongW ( Date: 27-May-2026 20:09) Posted:
Price has touched the lower boundary of the descending channel. If it bounce off the 50EMA (32.5), then pull back may have ended
If it close below 50EMA, next support lies at S1 (30)
ahberngh ( Date: 27-May-2026 19:50) Posted:
However, if the 50d ma were to cross below the 200d ma, I would be worried,
That is a death cross. |
|
|
|
Price has touched the lower boundary of the descending channel. If it bounce off the 50EMA (32.5), then pull back may have ended
If it close below 50EMA, next support lies at S1 (30)
ahberngh ( Date: 27-May-2026 19:50) Posted:
However, if the 50d ma were to cross below the 200d ma, I would be worried,
That is a death cross. |
|
Wait for more update from its recent positive news flow. Revenue up 30% , hope for potential profitability
Joelton ( Date: 11-May-2026 10:16) Posted:
IX Biopharma - Restructuring of Consumer Business and Update on Proposed Joint Venture with Orion Speciality Labs
Internal Restructuring
- Ligo Pharma Pte Ltd: iX Biopharma is consolidating its consumer business assets (Australian/HK subsidiaries and the WaferiX DTC platform) into this newly incorporated, 100% owned holding company.
- Asset Split: Ligo will be the vehicle for the US strategy . iX retains the Wafermine drug product, regulatory assets, and US Department of Defence (DoD) contract obligations.
- Financial Impact: The Board confirmed this is an intra-group reorganisation with no material impact on consolidated net tangible assets or earnings per share for the current financial year.
US Strategy & Rationale
-
Immediate Commercialization: The 503A/B compounding framework allows for the immediate commercialization of approximately 40 formulations without waiting for FDA approval.
-
DTC Telehealth: The strategy focuses on building a direct-to-consumer telehealth business. The Board notes that these businesses often trade at valuation premiums and benefit from iX' s patented sublingual technology.
-
Peptide Opportunity: iX identifies peptides as a major opportunity following the removal of 12 peptides from the restricted list in early 2026. The company claims a first-mover advantage due to its sublingual delivery technology.
-
Local Manufacturing: The announcement states that US-based manufacturing is operationally necessary to avoid tariff exposure and supply chain uncertainties inherent in shipping from Australia.
- Future Exit: The standalone structure is intended to preserve flexibility for future corporate actions, including potential listings on the SGX-ST or NASDAQ.
Joint Venture Update
- Orion & GLD: iX is in advanced discussions with GLD Partners, LP and Orion Specialty Labs to incorporate Orion into the Ligo structure.
- Status: GLD would become a co-shareholder of Ligo. Discussions have progressed from a simpler arrangement in November 2025 to a more substantive joint venture structure.
|
|
However, if the 50d ma were to cross below the 200d ma, I would be worried,
That is a death cross.
Although the 5d and 25d ma' s are downtrending for the moment, I am
not worried.
I am a longer term investor.
I have looked at the 100d and 200d ma' s, both of which are pointing up.
These are more important for me.
Just my opinion.
I think they switched to Eurosports recently.
kye_lin ( Date: 26-May-2026 21:18) Posted:
Cashing out. Run road already??
JurongW ( Date: 26-May-2026 20:32) Posted:
|
|
|
